Eevia Health Plc receives a 3,3 MSEK/0,33 MEUR sales order for bilberry extract
Eevia Health Plc, (”Eevia” or ”The Company”), has received a sales order from its Australian distributor Ingredients Plus. Ingredients Plus serves leading nutraceutical brands in Oceania and Asia with high-quality ingredients. The end customer is a major natural health company based out of Sydney, Australia selling its products across Asia and Oceania.
The sales value of this order is c. 334 000 EUR, and the product is Feno-Myrtillus bilberry extract standardized with 36% anthocyanins. The order is in line with expectations for repeat sales of this product going forward.
“With the war in Ukraine, which has been a large bilberry exporter, Eevia Health is being sought out as a supplier of organic berry extracts, since we are located next to the berry harvest areas in Finland and Sweden,” says Stein Ulve, CEO of Eevia.
The Feno-Myrtillus® product range is extracted from arctic bilberries. The powder is deep blue, almost black due to the high concentration of anthocyanins, a polyphenol with benefits to human health.
This disclosure contains information that EEVIA HEALTH PLC is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on May 11, 2022.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc Gabriella Beni, CFO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com gabriella@eeviahealth.com
Telephone: +358 400 22 5967 +358 407 48 8666
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients to dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product; Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, Chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. The factory operates near the raw material harvest areas. A uniquely short value chain enables an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn @EeviaHealth.